DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
AstraZeneca - 1 Ann Falsey - 1
Top related locs:
SUA Germania Franţa Spania Oxford Europa Rochester
Top related orgs:
Universitatea Oxford - 1 Mediafax - 1 Universităţii - 1

Search resuls for: "Ann Falsey"


3 mentions found


☆ FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks
  + stars: | 2023-03-01 | by ( Spencer Kimball | ) www.cnbc.com   time to read: +6 min
Ten of the FDA advisors said the safety data on GSK's vaccine was adequate, while two said it was not. The panel reached a similar conclusion in a narrow 7 to 4 vote Tuesday on Pfizer's application to clear its RSV vaccine. While the advisors erred toward recommending approval, they also raised concern over a possible link to Guillain-Barre syndrome. Both companies have asked the FDA to approve their RSV shot for adults ages 60 and older. The FDA said the cases are possibly related to either GSK's RSV vaccine or the flu shot that was administered with it.
☆ RSV hospitalization rate for seniors is 10 times higher than usual for this point in the season
  + stars: | 2022-11-15 | by ( Jen Christensen | ) edition.cnn.com   time to read: +7 min
In the years before the Covid-19 pandemic, hospitalization rates for seniors were about 10 times lower at this point in the season. Based on best estimates, there are between 10,000 and 15,000 adult deaths in the United States from RSV each year and around 150,000 hospitalizations for RSV, Falsey said. Adults with weakened immune systems need to be careful in RSV season. Doctors’ offices have swab tests that can determine whether an illness is flu, RSV or Covid. Protective measures for this busy RSV season will sound familiar: Wash your hands frequently, disinfect surfaces, and wear a mask in crowded spaces.
☆ Nou studiu realizat în SUA: Vaccinul AstraZeneca are o eficienţă 100% împotriva bolii severe şi a spitalizării
  + stars: | 2021-03-22 | by ( ) www.jurnal.md   time to read: +4 min
Sursa foto: lci.frNou studiu realizat în SUA: Vaccinul AstraZeneca are o eficienţă 100% împotriva bolii severe şi a spitalizăriiVaccinul AstraZeneca are o eficienţă de 79% în prevenirea bolii simptomatice şi de 100% împotriva celei severe şi a spitalizării, potrivit unui studiu efectuat în SUA. Rezultatele unui amplu studiu din SUA au arătat că vaccinul împotriva coronavirusului dezvoltat de AstraZeneca şi Universitatea Oxford are o eficienţă de 79% în prevenirea bolilor simptomatice şi de 100% împotriva bolilor severe şi a spitalizării, relatează Mediafax citând CNBC. Prin comparaţie, vaccinul Moderna are o eficacitate mai mare de 94% în prevenirea coronavirusului, iar vaccinul Pfizer-BioNTech s-a dovedit a avea 95% eficienţă. AstraZeneca a declarat luni, într-un comunicat, că un consiliu independent care a analizat vaccinul său nu a identificat probleme de siguranţă legate de acesta. În special, vaccinul Oxford-AstraZeneca a avut o eficienţă de 80% în prevenirea coronavirusului la participanţii cu vârsta de peste 65 de ani.
Persons: AstraZeneca, Ann Falsey Organizations: Universitatea Oxford, Mediafax, Universităţii Locations: SUA, Germania, Franţa, Italia, Spania, Oxford, Europa, Rochester
0 next >>
Total: 3